Persistence of maternal antibodies against goat pox virus in goat kids.

goat kid goat pox passive immunity vaccine

Journal

Journal of veterinary internal medicine
ISSN: 1939-1676
Titre abrégé: J Vet Intern Med
Pays: United States
ID NLM: 8708660

Informations de publication

Date de publication:
31 Jul 2024
Historique:
received: 29 09 2023
accepted: 10 06 2024
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 1 8 2024
Statut: aheadofprint

Résumé

In goat kids, choosing the appropriate age to administer the first dose of goat pox disease (GTP) vaccine requires knowing when maternal antibody decline concentrations. Determine the persistence of maternal antibodies against goat pox virus (GTPV) in goat kids. Twenty Saanen goat kids from birth to 120 days old. In 2 groups, including: control (receiving colostrum from nonvaccinated does) and treatment (receiving colostrum from vaccinated does). On zero, 3, 7, 14, 21, 28, 42, 56, 70, 100 and 120 days after the birth, virus neutralization test was used to measure the serum concentration of antibodies against GTPV. At the age of 56 days, the first seronegative goat kids (n = 2) were recorded in the treatment group. At the age of 120 days, all the goat kids in the treatment group were seronegative. The average virus neutralization index (VNI) of the goat kids became negative at the age of 100 to 120 days. All goat kids in the control group were negative at all times. One hundred to 120 days of the age seems to be the time to administer the first GTP vaccine in the goat kids with passive immunity against goat pox.

Sections du résumé

BACKGROUND BACKGROUND
In goat kids, choosing the appropriate age to administer the first dose of goat pox disease (GTP) vaccine requires knowing when maternal antibody decline concentrations.
OBJECTIVE OBJECTIVE
Determine the persistence of maternal antibodies against goat pox virus (GTPV) in goat kids.
ANIMALS METHODS
Twenty Saanen goat kids from birth to 120 days old.
METHODS METHODS
In 2 groups, including: control (receiving colostrum from nonvaccinated does) and treatment (receiving colostrum from vaccinated does). On zero, 3, 7, 14, 21, 28, 42, 56, 70, 100 and 120 days after the birth, virus neutralization test was used to measure the serum concentration of antibodies against GTPV.
RESULTS RESULTS
At the age of 56 days, the first seronegative goat kids (n = 2) were recorded in the treatment group. At the age of 120 days, all the goat kids in the treatment group were seronegative. The average virus neutralization index (VNI) of the goat kids became negative at the age of 100 to 120 days. All goat kids in the control group were negative at all times.
CONCLUSIONS AND CLINICAL IMPORTANCE CONCLUSIONS
One hundred to 120 days of the age seems to be the time to administer the first GTP vaccine in the goat kids with passive immunity against goat pox.

Identifiants

pubmed: 39086156
doi: 10.1111/jvim.17135
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024 The Author(s). Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.

Références

Mirzaie K, Barani SM, Bokaie S. A review of sheep pox and goat pox: perspective of their control and eradication in Iran. J Adv Vet Anim Res. 2015;2(4):373‐381.
Hurisa TT, Jing Z, Jia H, et al. A review on Sheeppox and Goatpox: insight of epidemiology, diagnosis, treatment and control measures in Ethiopia. J Infect Dis Epidemiol. 2018;4(3):1‐8.
Tulman ER, Afonso CL, Lu Z, et al. The genomes of Sheeppox and Goatpox viruses. J Virol. 2002;76(12):6054‐6061.
Zewdie G, Derese G, Getachew B, Belay H, Akalu M. Review of sheep and goat pox disease: current updates on epidemiology, diagnosis, prevention and control measures in Ethiopia. Anim Dis. 2021;1(28):1‐10.
Hamdi J, Bamouh Z, Jazouli M, et al. Experimental evaluation of the cross‐protection between Sheeppox and bovine lumpy skin vaccines. Sci Rep. 2020;10(8888):278‐287.
Zangana IK, Abdullah MA. Epidemiological, clinical and histopathological studies of lamb and kid pox in Duhok, Iraq. Bulg J Vet Med. 2013;16(2):133‐138.
Emady M, Ahmadi N, Kafi M, et al. Preliminary studies on reproductive activities of local Abadeh does, Fars province, southern Iran. Iran J Vet Res. 2006;7(3):17‐22.
Wondimu A, Tassew H, Gelaye E, et al. Outbreak investigation and molecular detection of pox virus circulating in sheep and goats in selected districts of west Gojjam and Awi zones northwest, Ethiopia. Vet Med (Auckl). 2021;12:303‐315.
Yang M, Zou Y, Wu ZH, Li SL, Cao ZJ. Colostrum quality affects immune system establishment and intestinal development of neonatal calves. J Dairy Sci. 2015;98(10):7153‐7163.
Day MJ, Schultz RD. Veterinary Immunology—Principles and Practice. 2nd ed. Bristol, UK: CRC Press; 2014.
Dowling DJ, Levy O. Ontogeny of early life immunity. Trends Immunol. 2014;35(7):299‐310.
Ebrahimi‐Jam MH, Yousefi AR, Varshovi HR, Hedayati Z, Aghaebrahimian M. Determining the duration of maternal immunity against sheep pox in lambs. Viral Immunol. 2022;35(4):310‐317.
Abdollahi M, Lotfi M, Lotfollahzadeh S, Adibi M, Kamalzadeh M, Firuzyar S. Determining the decreasing trend of maternal immunity against small ruminant morbillivirus in goat kids. Vet Med Sci. 2023;9(4):1818‐1823.
Abdollahi M, Lotfollahzadeh S, Salehi TZ, Moosakhani F, Raoofi A. Assessment of the duration of maternal‐derived antibodies specific to the Mycoplasma agalactiae vaccine in goat kids. Vet Med Sci. 2022;8(5):2119‐2125.
Elfil M, Negida A. Sampling methods in clinical research; an educational review. Emerg. 2017;5(1):52‐55.
Buckrell BC. Applications of ultrasonography in reproduction in sheep and goats. Theriogenology. 1988;29(1):71‐84.
Matthews J. Weak Kids in Diseases of the Goat. 4th ed. New York, US: Wiley Blackwell; 2016.
deVries RB, Wever KE, Avey MT, et al. The usefulness of systematic reviews of animal experiments for the design of preclinical and clinical studies. ILAR J. 2014;55(3):427‐437.
OIE. Chapter 3.8.12. Sheep pox and goat pox. Terrestrial Manual. Paris: OIE; 2018.
Abdollahi M, Lotfollahzadeh S, Nazem Shirazi MH, Shokrpoor S, Moosakhani F, Partovi Nasr M. First identification of Mycoplasma capricolum subspecies capripneumoniae in goats in Iran. Vet Res Forum. 2023;14(2):109‐112.
Bhanuprakash V, Hosamani M, Venkatesan G, Singh RK. Long‐term protective immunity to goatpox in goats after a single immunization with a live attenuated goatpox vaccine. Arch Virol. 2022;167(10):2035‐2040.
Fay P, Limon G, Ulziibat G, et al. A field study evaluating the humoral immune response in Mongolian sheep vaccinated against sheeppox virus. Transbound Emerg Dis. 2022;69(4):1837‐1846.
Gari G, Abie G, Gizaw D, et al. Evaluation of the safety, immunogenicity and efficacy of 3 capripoxvirus vaccine strains against lumpy skin disease virus. Vaccine. 2015;33(28):3256‐3261.
Bowden TR, Coupar BE, Babiuk SL, et al. Detection of antibodies specific for sheeppox and goatpox viruses using recombinant capripoxvirus antigens in an indirect enzyme‐linked immunosorbent assay. J Virol Methods. 2009;161(1):19‐29.
Gulyaz V. Investigation of immunity in the lambs borned from ewes vaccinated with sheep and goat pox vaccine. Pendik Vet Mikrobiyol Derg. 1999;30(1):55‐62.
Tizard IR. The Administration of Vaccines in Vaccines for Veterinarians. 1st ed. Amsterdam, Netherlands: Elsevier Health Sciences; 2020.

Auteurs

Mostafa Abdollahi (M)

Department of Clinical Sciences, Faculty of Veterinary Medicine, Semnan University, Semnan, Iran.

Mohsen Lotfi (M)

Department of Quality Control, Razi Vaccine and Serum Research, Education and Extension Organization (AREEO), Karaj, Iran.

Samad Lotfollahzadeh (S)

Department of Internal Medicine, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.

Mohammad Reza Mokhber Dezfouli (MRM)

Department of Internal Medicine, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.

Maryam Adibi (M)

Department of Quality Control, Razi Vaccine and Serum Research, Education and Extension Organization (AREEO), Karaj, Iran.

Morteza Kamalzadeh (M)

Department of Quality Control, Razi Vaccine and Serum Research, Education and Extension Organization (AREEO), Karaj, Iran.

Sajjad Firuzyar (S)

Department of Quality Control, Razi Vaccine and Serum Research, Education and Extension Organization (AREEO), Karaj, Iran.

Classifications MeSH